
FDA chief has no 'plans' for abortion pill policy changes but continues safety review
Fox News
FDA's Makary commits to reviewing abortion pill mifepristone safety data while listening to concerns, stating he has no plans for policy changes.
Adam Sabes is a writer for Fox News Digital. Story tips can be sent to Adam.Sabes@fox.com and on Twitter @asabes10.
His comments mirror those he made during the Semafor World Economy Summit in April.
During the summit, Makary said he has "no plans to take action" that would restrict the abortion drug's availability, but cautioned the agency wouldn't hesitate to act if the data suggested there was a safety issue.
More Related News













